2022
Characteristics and productivity of the chiropractic workforce of the Veterans Health Administration
Corcoran KL, Peterson DR, Zhao X, Moran EA, Lisi AJ. Characteristics and productivity of the chiropractic workforce of the Veterans Health Administration. Chiropractic & Manual Therapies 2022, 30: 18. PMID: 35410303, PMCID: PMC8996387, DOI: 10.1186/s12998-022-00429-1.Peer-Reviewed Original ResearchConceptsVeterans Health AdministrationTotal work relative value unitsHealth AdministrationChiropractic workforceWork relative value unitsUnited States Veterans Health AdministrationFull-time equivalentsCharacteristics of chiropractorsVHA administrative dataHealthcare systemMultivariable regression modelsClinical full-time equivalentChiropractic careClinical productivityVHA facilitiesVHA's experienceCare deliveryOlder ageChiropractorsRelative value unitsFiscal year 2016Administrative dataAdministration
2021
High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder
Herring AA, Vosooghi AA, Luftig J, Anderson ES, Zhao X, Dziura J, Hawk KF, McCormack RP, Saxon A, D’Onofrio G. High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder. JAMA Network Open 2021, 4: e2117128. PMID: 34264326, PMCID: PMC8283555, DOI: 10.1001/jamanetworkopen.2021.17128.Peer-Reviewed Original ResearchConceptsOpioid use disorderEmergency departmentBuprenorphine inductionRespiratory depressionAdverse eventsUse disordersUntreated opioid use disorderSerious adverse eventsFurther prospective investigationLength of stayUrban emergency departmentSafety-net hospitalAdvanced practice practitionersElectronic health recordsUnique cliniciansSublingual buprenorphineBuprenorphine doseED visitsED encountersCase seriesED patientsED physiciansSupplemental oxygenMedian lengthUnique patientsCognitive performance as a predictor of healthcare transition in sickle cell disease
Saulsberry‐Abate A, Partanen M, Porter J, Podila P, Hodges J, King A, Wang W, Schreiber J, Zhao X, Kang G, Jacola L, Hankins J. Cognitive performance as a predictor of healthcare transition in sickle cell disease. British Journal Of Haematology 2021, 192: 1082-1091. PMID: 33570182, PMCID: PMC8092972, DOI: 10.1111/bjh.17351.Peer-Reviewed Original Research
2019
Impact of MYCN status on response of high-risk neuroblastoma to neoadjuvant chemotherapy
Yanishevski D, McCarville M, Doubrovin M, Spiegl H, Zhao X, Lu Z, Federico S, Furman W, Murphy A, Davidoff A. Impact of MYCN status on response of high-risk neuroblastoma to neoadjuvant chemotherapy. Journal Of Pediatric Surgery 2019, 55: 130-134. PMID: 31685267, DOI: 10.1016/j.jpedsurg.2019.09.067.Peer-Reviewed Original ResearchConceptsNon-amplified tumorsNeoadjuvant chemotherapyHigh-risk neuroblastomaCurie scoreTumor responseMYCN amplificationGreater mean percentage reductionHigh-risk neuroblastoma patientsMetastatic disease responsePrimary tumor responsePercentage of patientsPrimary tumor volumeAggressive clinical phenotypeMean percentage reductionPercentage volume changeLocoregional diseaseSurgical resectionMetastatic sitesNeuroblastoma patientsPrimary tumorTumor resectionTumor volumeCT scanMYCN statusChemotherapy